General Information of the Compound
Compound ID |
CP0007430
|
||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Compound Name |
IBRUTINIB
Show/Hide
|
||||||||||||||||||
Synonyms |
1X70OSD4VX
CRA-032765
IMBRUVICA
Ibrutinib
Ibrutinib (BTK inhibitor)
Ibrutinib (PCI-32765)
PCI 32765
PCI-32765
PCI-32765 (Ibrutinib)
Pc-32765
UNII-1X70OSD4VX
Show/Hide
|
||||||||||||||||||
Structure |
|
||||||||||||||||||
Formula |
C25H24N6O2
|
||||||||||||||||||
Molecular Weight |
440.507
|
||||||||||||||||||
Canonical SMILES |
Nc1ncnc2n(nc(-c3ccc(Oc4ccccc4)cc3)c12)[C@@H]1CCCN(C1)C(=O)C=C
Show/Hide
|
||||||||||||||||||
InChI |
InChI=1S/C25H24N6O2/c1-2-21(32)30-14-6-7-18(15-30)31-25-22(24(26)27-16-28-25)23(29-31)17-10-12-20(13-11-17)33-19-8-4-3-5-9-19/h2-5,8-13,16,18H,1,6-7,14-15H2,(H2,26,27,28)/t18-/m1/s1
Show/Hide
|
||||||||||||||||||
InChIKey |
XYFPWWZEPKGCCK-GOSISDBHSA-N
|
||||||||||||||||||
CAS |
936563-96-1
|
||||||||||||||||||
Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
PubChem ID | |||||||||||||||||||
ChEMBL ID | |||||||||||||||||||
DrugBank ID |
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
---|
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT01669, Cytoplasmic tyrosine-protein kinase BMX
Protein ID: PT00922, Epidermal growth factor receptor
Cell-based Assay
Protein ID: PT01204, Receptor-type tyrosine-protein kinase FLT3
Protein ID: PT01308, Tyrosine-protein kinase BTK
Cell-based Assay
Biochemical Assays
Protein ID: PT01314, Tyrosine-protein kinase ITK/TSK
Protein ID: PT00892, Tyrosine-protein kinase JAK3
Protein ID: PT00875, Tyrosine-protein kinase Lyn
Protein ID: PT01660, Tyrosine-protein kinase Tec
Cell Viability or Cytotoxicity Assay
Clinical Information about the Compound
Drug 1 ( Ibrutinib )
Drug Name | Ibrutinib | ||
---|---|---|---|
Company | Janssen Biotech; Pharmacyclics | ||
Indication | |||
Target(s) |